Helicobacter pylori is a highly adaptive pathogen that escapes host bacterial defenses (i.e., gastric acid and humoral immunity) leading to chronic infection. The broad, long-term objective of this proposal is to elucidate the factors contributing to the failure of the initial host immune response to eradicate H. pylori. The specific hypothesis behind the proposed research is that a defective DC-dependent adaptive immune mechanism against acute H. pylori infection leads to a failure to eradicate H. pylori. This hypothesis is based on the following observations. First, DCs are the most potent antigen presenting cells (APCs) that upon activation can migrate to secondary lymphoid organs to prime an adaptive T cell response. Second, many studies have implicated the involvement of DCs in the pathogenesis/response to a variety of intestinal bacterial pathogens. Third, a type 1 T helper (Th1) response, induced by APCs, has recently been shown to be crucial for vaccine-induced protection against H. pylori.
The specific aims are to: 1. Determine the time course of DC recruitment from blood to H. pylori infected stomach and the role of CCR2 and its ligand, MCP-1, in DC recruitment. Transgenic CD11cp-DTR-GFP C57BL/6 mice orally challenged with H. pylori will be assessed for DC recruitment by FACS analysis. The role of CCR2 and tissue MCP-1 in DC recruitment will be studied using CCR2-/- mice and neutralization of MCP-1. 2. Dissect the steps in the DC-H. pylori interaction in vivo and in DC migration to secondary lymphoid organs. DCs from stomach associated lymph nodes of H. pylori-infected mice will be isolated FACS sorting and their reactivity against H.pylori will be assess by coculturing DCs with H. pylori-specific T cells from immune mice. In vivo trafficking of H. pylori via DC will be assessed by red fluorochrome-labeled H. pylori. 3. Determine the functional significance of DCs in H. pylori gastritis. Transgenic mice with diphtheria toxin-sensitive DCs will be used to assess the effect of transient DC depletion during acute and chronic H. pylori infection by administrating diphtheria toxin. The role of CCR2 in acute and chronic H. pylori gastritis will also be addressed using CCR2-/- mice. The health relatedness of the project is to understand the immune dysregulation that underlies H. pylori-induced chronic gastritis which may lead to novel targets or vaccine strategies for the prevention or treatment of emerging antibioticresistant H. pylori.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Clinical Investigator Award (CIA) (K08)
Project #
Application #
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Podskalny, Judith M,
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Internal Medicine/Medicine
Schools of Medicine
Ann Arbor
United States
Zip Code
Cole, Tyler S; Zhang, Min; Standiford, Theodore J et al. (2012) IRAK-M modulates expression of IL-10 and cell surface markers CD80 and MHC II after bacterial re-stimulation of tolerized dendritic cells. Immunol Lett 144:49-59
Luther, Jay; Owyang, Stephanie Y; Takeuchi, Tomomi et al. (2011) Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis. Gut 60:1479-86
Kao, John Y; Zhang, Min; Miller, Mark J et al. (2010) Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 138:1046-54
Luther, Jay; Dave, Maneesh; Higgins, Peter D R et al. (2010) Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 16:1077-84
Zhang, Min; Berndt, Bradford E; Eaton, Kathryn A et al. (2008) Helicobacter pylori-pulsed dendritic cells induce H. pylori-specific immunity in mice. Helicobacter 13:200-8